LabCorp Announces Departure of John Ratliff, Names New LabCorp Diagnostics Leadership

John Ratliff is departing the company to pursue another opportunity Dr. Brian Caveney has been named executive vice president and president of Diagnostics Mark Schroeder has been named executive vice president and president of Diagnostics laboratory operations and global supply chain These new

LabCorp Announces 2019 Third Quarter Results and Updates 2019 Guidance

Q3 revenue of $2.9 billion , up 3.4% over $2.8 billion last year Q3 diluted EPS of $2.25 , down from $3.10 last year, which included the net gain on the disposition of the Food Solutions business of $1.22 per share Q3 adjusted EPS of $2.90 , up 5.8% over $2.74 last year Q3 free cash flow of $363

LabCorp Expands Services in Northwest Indiana and Surrounding Region Through Acquisition of Diagnostic Clinical Laboratory Assets From South Bend Medical Foundation

 South Bend Medical Foundation and LabCorp Also Establish Pathology Services Collaboration to Serve Customers and Patients Across Four States BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 22, 2019-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient

HealthEC, LabCorp, and The New Jersey Primary Care Association Announce Strategic Collaboration to Advance Value-Based Care at Community Health Centers

Agreement Establishes Database and Information Exchange Platform to Facilitate Care-Delivery Collaboration Between Participating New Jersey FQHCs Through LabCorp’s Care Intelligence Module BURLINGTON, N.C. & EDISON, N.J. & HAMILTON, N.J. --(BUSINESS WIRE)--Oct.